SCHEMBL25252203

SCHEMBL25252203

COC(=O)c1cnc(N2CCN(C(=O)OC(C)(C)C)CC2)nc1OC

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 1/20 0.57
GPR119 Q8TDV5 10/20 0.48
ACHE P22303 2/20 0.48
MAPT P10636 2/20 0.47
CKS1B P61024 2/20 0.45
SKP1 P63208 2/20 0.45
SKP2 Q13309 2/20 0.45
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
MEN1 O00255 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CHRNA7 P36544 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30422178 1.00 PTPN11 (0.57) PTPN11GPR119ACHEMAPTCKS1B
SCHEMBL30422517 0.90 PTPN11 (0.58) PTPN11GPR119ACHEMAPTCKS1B
SCHEMBL22006096 0.83 PTPN11 (0.58) PTPN11GPR119ACHEMAPTCKS1B
SCHEMBL25215112 0.81 PTPN11 (0.52) PTPN11GPR119ACHEMAPTCKS1B
SCHEMBL3607189 0.81 GPR119 (0.57) PTPN11GPR119ACHEMAPTCKS1B
SCHEMBL16333807 0.81 MAP4K4 (0.52) PTPN11GPR119MAPTCKS1BSKP1
SCHEMBL27316944 0.80 POLB (0.55) PTPN11MAPTSMN1; SMN2
SCHEMBL25216474 0.79 PTPN11 (0.56) PTPN11GPR119ACHEMAPTCKS1B
SCHEMBL30422622 0.79 PTPN11 (0.56) PTPN11GPR119ACHEMAPTCKS1B
SCHEMBL25244358 0.78 PTPN11 (0.48) PTPN11GPR119ACHEMAPTCKS1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023102231-A1 5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND METHODS OF USING THE SAME RGENTA THERAPEUTICS, INC. (US) 2023-06-08 WO disclosed